🇺🇸 FDA
Pipeline program

All-trans retinoic acid

XJTU1AF2019LSK-077

Phase 1 small_molecule active

Quick answer

All-trans retinoic acid for Acute Myeloid Leukemia is a Phase 1 program (small_molecule) at The First People's Hospital of Lianyungang with 1 ClinicalTrials.gov record(s).

Program details

Company
The First People's Hospital of Lianyungang
Indication
Acute Myeloid Leukemia
Phase
Phase 1
Modality
small_molecule
Status
active

Clinical trials